Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Health Care Utilization After Paraprofessional-administered Substance Use Screening, Brief Intervention, and Referral to Treatment: A Multi-level Cost-offset Analysis.

Tytuł:
Health Care Utilization After Paraprofessional-administered Substance Use Screening, Brief Intervention, and Referral to Treatment: A Multi-level Cost-offset Analysis.
Autorzy:
Paltzer J; Population Health Institute, University of Wisconsin-Madison, College of Nursing & Health Care Professions, Grand Canyon University.
Moberg DP; Population Health Institute, University of Wisconsin-Madison.
Burns M; Department of Population Health Sciences, University of Wisconsin, Madison, WI.
Brown RL; ConcertoHealth, Kalamazoo, MI.
Źródło:
Medical care [Med Care] 2019 Sep; Vol. 57 (9), pp. 673-679.
Typ publikacji:
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Philadelphia, etc., Lippincott.
MeSH Terms:
Health Care Costs/*statistics & numerical data
Patient Acceptance of Health Care/*statistics & numerical data
Primary Health Care/*economics
Substance-Related Disorders/*economics
Substance-Related Disorders/*therapy
Adult ; Cost-Benefit Analysis ; Costs and Cost Analysis ; Female ; Health Plan Implementation ; Humans ; Linear Models ; Male ; Mass Screening/economics ; Mass Screening/methods ; Multilevel Analysis ; Primary Health Care/methods ; Psychotherapy, Brief/economics ; Referral and Consultation/economics ; Substance-Related Disorders/diagnosis
References:
Alcohol Clin Exp Res. 2002 Jan;26(1):36-43. (PMID: 11821652)
JAMA. 2018 Mar 13;319(10):1013-1023. (PMID: 29536097)
J Subst Abuse Treat. 2017 Aug;79:6-11. (PMID: 28673528)
Ann Intern Med. 2004 Apr 6;140(7):557-68. (PMID: 15068985)
J Trauma. 2005 Sep;59(3 Suppl):S112-8; discussion S124-33. (PMID: 16355046)
Health Educ Behav. 2003 Jun;30(3):305-21. (PMID: 19731498)
Lancet. 2018 Sep 22;392(10152):1015-1035. (PMID: 30146330)
Popul Health Manag. 2012 Oct;15(5):253-60. (PMID: 22401152)
Am J Prev Med. 2011 Nov;41(5):516-24. (PMID: 22011424)
Addiction. 2017 Feb;112 Suppl 2:92-100. (PMID: 28074565)
Alcohol Alcohol. 2016 Jul;51(4):422-7. (PMID: 26574600)
BMJ. 1990 Nov 3;301(6759):1031-4. (PMID: 2249053)
Am J Prev Med. 2015 Nov;49(5):e73-e79. (PMID: 26477807)
Alcohol Res. 2013;35(2):155-73. (PMID: 24881324)
Med Care. 2018 Feb;56(2):146-152. (PMID: 29256973)
Addiction. 2009 Dec;104(12):1981-90. (PMID: 19804464)
Subst Abus. 2007;28(3):7-30. (PMID: 18077300)
J Am Board Fam Med. 2018 Mar-Apr;31(2):243-251. (PMID: 29535241)
Diabetes Care. 2009 Nov;32(11):2123-32. (PMID: 19875607)
J Behav Health Serv Res. 2000 Nov;27(4):446-53. (PMID: 11070638)
Med Care. 2010 Jan;48(1):18-24. (PMID: 19927016)
Public Health Rev. 2017 Dec 29;38:31. (PMID: 29450101)
Ann Behav Med. 2009 Jun;37(3):335-42. (PMID: 19707840)
Addiction. 2017 Feb;112 Suppl 2:43-53. (PMID: 28074561)
Addiction. 2017 Feb;112 Suppl 2:23-33. (PMID: 28074571)
Lancet. 2017 Jan 14;389(10065):186-195. (PMID: 27988144)
Fam Med. 2012 Sep;44(8):555-63. (PMID: 22930120)
J Behav Health Serv Res. 2017 Jan;44(1):102-112. (PMID: 27221694)
Addiction. 2008 Jun;103(6):1039-47. (PMID: 18373724)
J Addict Med. 2012 Mar;6(1):50-6. (PMID: 21979821)
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. (PMID: 28033313)
Alcohol Alcohol. 2006 Nov-Dec;41(6):624-31. (PMID: 17035245)
Arch Intern Med. 2005 May 9;165(9):986-95. (PMID: 15883236)
Ann Intern Med. 2012 Nov 6;157(9):645-54. (PMID: 23007881)
Med Care. 2007 Feb;45(2):177-82. (PMID: 17224781)
Ann Surg. 2005 Apr;241(4):541-50. (PMID: 15798453)
Drug Alcohol Depend. 2009 Jan 1;99(1-3):280-95. (PMID: 18929451)
J Stud Alcohol Drugs. 2012 Nov;73(6):899-910. (PMID: 23036207)
J Stud Alcohol. 2005 May;66(3):361-8. (PMID: 16047525)
BMJ. 2013 Jan 09;346:e8501. (PMID: 23303891)
J Subst Abuse Treat. 2015 Jun;53:1-8. (PMID: 25648375)
JAMA Psychiatry. 2017 Sep 1;74(9):911-923. (PMID: 28793133)
Addiction. 2015 Sep;110(9):1404-15. (PMID: 25913697)
Am J Manag Care. 2014 Apr 01;20(4):e113-21. (PMID: 24884956)
Grant Information:
R03 AA025196 United States AA NIAAA NIH HHS
Entry Date(s):
Date Created: 20190712 Date Completed: 20200130 Latest Revision: 20200901
Update Code:
20240105
PubMed Central ID:
PMC6690790
DOI:
10.1097/MLR.0000000000001162
PMID:
31295165
Czasopismo naukowe
Background: Authorities recommend universal substance use screening, brief intervention, and referral to treatment (SBIRT) for all (ie, universal) adult primary care patients.
Objective: The objective of this study was to examine long-term (24-mo) changes in health care utilization and costs associated with receipt of universal substance use SBIRT implemented by paraprofessionals in primary care settings.
Research Design: This study used a difference-in-differences design and Medicaid administrative data to assess changes in health care use among Medicaid beneficiaries receiving SBIRT. The difference-in-differences estimates were used in a Monte Carlo simulation to estimate potential cost-offsets associated with SBIRT.
Subjects: The treatment patients were Medicaid beneficiaries who completed a 4-question substance use screen as part of an SBIRT demonstration program between 2006 and 2011. Comparison Medicaid patients were randomly selected from matched clinics in Wisconsin.
Measures: The study includes 4 health care utilization measures: outpatient days; inpatient length of stay; inpatient admissions; and emergency department admissions. Each outcome was assigned a unit cost based on mean Wisconsin Medicaid fee-for-service reimbursement amounts.
Results: We found an annual increase of 1.68 outpatient days (P=0.027) and a nonsignificant annual decrease in inpatient days of 0.67 days (P=0.087) associated with SBIRT. The estimates indicate that the cost of a universal SBIRT program could be offset by reductions in inpatient utilization with an annual net cost savings of $782 per patient.
Conclusions: Paraprofessional-delivered universal SBIRT is likely to yield health care cost savings and is a cost-effective mechanism for integrating behavioral health services in primary care settings.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies